Anticoagulation and inhibition of nitric oxide synthase influence hepatic hypoxia after monocrotaline exposure
- 15 August 2006
- journal article
- Published by Elsevier in Toxicology
- Vol. 225 (2-3) , 128-137
- https://doi.org/10.1016/j.tox.2006.05.016
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Excess l-arginine restores endothelium-dependent relaxation impaired by monocrotaline pyrroleToxicology and Applied Pharmacology, 2005
- Liver inflammation during monocrotaline hepatotoxicityToxicology, 2003
- Anticoagulants Prevent Monocrotaline-Induced Hepatic Parenchymal Cell Injury but Not Endothelial Cell Injury in the RatToxicology and Applied Pharmacology, 2002
- Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure.Toxicological Sciences, 2002
- Nitric oxide in liver injuryHepatology, 1999
- Characterization of A Reproducible Rat Model of Hepatic Veno–Occlusive DiseaseHepatology, 1999
- Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox stateEuropean Journal of Biochemistry, 1998
- Role of nitric oxide in the regulation of the hepatic microcirculation in vivoJournal of Hepatology, 1997
- Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liverBritish Journal of Cancer, 1995
- Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicityCancer Chemotherapy and Pharmacology, 1987